Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03352427
Title Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring PDGFR Alterations
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Michigan Cancer Center

brain stem glioma

high grade glioma


Dasatinib + Everolimus

Age Groups: child | adult
Covered Countries USA

Additional content available in CKB BOOST